🇺🇸 FDA
Pipeline program

Diacomit 250 mg hard capsules, Matched Placebo will consist in caspules similar to the 250 and 500 mg capsules of stiripentol but with no active ingredient, Diacomit 500 mg hard capsules

STP226

Phase 3 small_molecule active

Quick answer

Diacomit 250 mg hard capsules, Matched Placebo will consist in caspules similar to the 250 and 500 mg capsules of stiripentol but with no active ingredient, Diacomit 500 mg hard capsules for Primary Hyperoxaluria (PH) of all subtypes (PH1, PH2 and PH3) is a Phase 3 program (small_molecule) at Biocodex with 1 ClinicalTrials.gov record(s).

Program details

Company
Biocodex
Indication
Primary Hyperoxaluria (PH) of all subtypes (PH1, PH2 and PH3)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials